Legal Marijuana Market to Reap Excessive Revenues By 2030

 Legal Marijuana Market Growth & Trends

The global legal marijuana market size is expected to reach USD 102.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 25.4% from 2023 to 2030. An increase in the rate of legalization of marijuana for medicinal and adult-use/recreational marijuana and the growing adoption of these products for the treatment of chronic ailments are the primary factors responsible for the growth of the market.

The oil and tinctures product segment held the largest revenue share of over 53.2% in 2022. Owing to its proven medical prowess in the treatment of various health indications and the increasing number of patients preferring it over usually prescribed medicines, governments of many countries are either legalizing or approving it for medicinal use. This is expected to be the key driver for the oil and tinctures segment.

The medical application segment captured the largest revenue share of over 82.6% in 2022 and is expected to grow at a significant CAGR during the forecast period. This can be attributed to the growing demand among the younger generation and patients for the prescription of cannabis for medicinal purposes. Medical marijuana is anticipated to grow at a steady rate throughout the forecast period owing to the legitimization in different geographies in comparison to recreational/ adult-use marijuana.

In the medical application segment, the chronic pain segment held the largest revenue share of over 25.0% in 2021. The medicinal use of cannabis has been embraced increasingly by governments and people all over the world. The sub-segment is expected to grow at a steady pace throughout the forecast period due to the increase in the use of marijuana for relieving pain symptoms across geographies.

North America led the market with a revenue share of over 78.8% in 2022. This is due to the fact that North America was one of the first regions to legitimize the use of medical and recreational cannabis owing to its vast consumer base. The COVID-19 pandemic has adversely affected the supply chain of legal cannabis as with other markets. The market also witnessed the effect of the supply chain disruptions during the pandemic. An increase in the number of countries legalizing it and an increase in the number of prescriptions filled for medicinal marijuana are an indication of the fact that the growth spur will continue post-pandemic.

Request a free sample copy or view report summary: Legal Marijuana Market Report

Legal Marijuana Market Report Highlights

• In 2022, the oil and tinctures product type segment accounted for the largest revenue share of over 53.2% owing to the low price and ease of accessibility of flowers compared to other products
• Based on application, the medical segment accounted for the largest revenue share of over 82.6% in 2022 owing to the high demand among millennials and patients for medicinal marijuana
• In the medical application segment, the chronic pain segment accounted for the largest revenue share of over 25.0% in 2021 owing to the rising adoption by the governments and people all over the world

Access Press Release@ https://www.grandviewresearch.com/press-release/global-legal-marijuana-market

Legal Marijuana Market Segmentation

Grand View Research has segmented the global legal marijuana market based on product type, application, and region:

Legal Marijuana Product Type Outlook (Revenue, USD Million, 2016 - 2030)

• Flower
• Oil and Tinctures

Legal Marijuana Application Outlook (Revenue, USD Million, 2016 - 2030)

• Medical
  • Cancer
  • Chronic Pain
  • Depression and Anxiety
  • Arthritis
  • Diabetes
  • Glaucoma
  • Migraines
  • Epilepsy
  • Multiple Sclerosis
  • AIDS
  • Amyotrophic Lateral Sclerosis
  • Alzheimer’s
  • Post-traumatic Stress Disorder (PTSD)
  • Parkinson's
  • Tourette’s
  • Others
• Adult Use

Legal Marijuana Regional Outlook (Revenue, USD Million, 2016 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Italy
  • Netherlands
  • Croatia
  • Poland
  • Czech Republic
  • Switzerland
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • Australia
  • New Zealand
• Latin America
  • Uruguay
  • Colombia
  • Mexico
  • Brazil
• Africa

List of Key Players in the Legal Marijuana Market

• Aurora Cannabis
• Canopy Growth Corporation
• Maricann Group, Inc.
• Aphria, Inc.
• Tilray
• The Cronos Group
• ABcann Medicinals, Inc.
• Lexaria Corp.
• Organigram Holding, Inc.
• GW Pharmaceuticals
• United Cannabis Corporation
• Tikun Olam, Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Radiodermatitis Market is Expected to Enhance $557.1 Million Revenue By 2030: Grand View Research Inc.

 

Radiodermatitis Market Growth & Trends

The global radiodermatitis market size is expected to reach USD 557.1 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.9% from 2023 to 2030. The market is expected to grow at an unprecedented rate owing to the growing prevalence of cancer patients undergoing radiation therapy. The unmet medical needs of patients in both emerging and developed nations are another factor that increases the demand for radiodermatitis treatment. As the prevalence of diabetes and obesity increases, these individuals are more likely to suffer from cancer. This factor is probably going to increase the cases of radiodermatitis and increase the need for radiation therapy. Furthermore, higher consumption of alcohol and smoking are additional cancer risk factors, which will certainly increase demand for radiodermatitis medications.

The COVID-19 pandemic has a significant impact on the radiodermatitis market. Various regions imposed restrictions or lockdowns of varying severity implemented to curb the pandemic, with different outcomes.Globally, many cancer centers have reported substantial decreases in the number of patients diagnosed with and treated for cancer during the pandemic. Hospitals across the globe have decreased radiotherapy treatment as there was a shift to support the COVID-19 pandemic. However, with the ease of the restrictions by the 3^rd quarter of 2020, radiotherapy treatment started to increase which resulted in the growth of the radiodermatitis market.

Asia Pacific dominated the overall market in terms of revenue and growth rate during the forecast period. The presence of increasing cancer research activities, advancing healthcare infrastructure, and expenditure are some of the factors responsible for garnering a greater share of the segment. As a result of unmet patient needs, Asia Pacific is also likely to have profitable expansion over the course of the projection period. The market's second-largest share was accounted for by North America. The increasing incidence of radiation burns along with the high demand for skin grafts and substitutes is expected to further drive the growth of this market.

Request a free sample copy or view report summary: Radiodermatitis Market Report

Radiodermatitis Market Report Highlights

• The topical products segment captured the largest share in the product segment in 2022. The dominant share is attributable to ease in availability, greater convenience, and superiority over oral products. Topical products are also anticipated to grow at an exponential rate owing to their availability in various formulations such as creams, gels, and ointments according to the requirement of the patient
• In 2022, the retail pharmacies segment accounted for a substantial share of the distribution channel segment owing to the rising number of pharmacies. The retail pharmacies may capture large percent of prescriptions written in the hospital 
• Due to the high number of cancer patients in this area, Asia Pacific held the highest share of the market
• North America held the second largest share owing to extensive R&D activities that have fueled high-potential growth opportunities. In addition, the availability of therapeutically advanced products across North America is one of the major factors contributing toward its high share
• The competition is marked by major players undertaking strategies such as product launches, distribution agreements, and strategic collaborations that have led to significant growth in their respective market share

Access Press Release@ https://www.grandviewresearch.com/press-release/global-radiodermatitis-market

Radiodermatitis Market Segmentation

Grand View Research has segmented the global radiodermatitis market on the basis of product, distribution channel, and region:

Radiodermatitis Product Outlook (Revenue, USD Million, 2018 - 2030)

• Topical
  • Corticosteroids
  • Hydrophilic Creams
  • Antibiotics
  • Others
• Oral
• Dressings
  • Hydrogel & Hydrocolloid Dressings
  • No Sting Barrier Film
  • Honey-Impregnated Gauze
  • Silicone-Coated Dressings
  • Others

Radiodermatitis Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Radiodermatitis Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players of the Radiodermatitis Market

• Stratpharma AG
• Smith & Nephew
• Molnlycke Health Care AB
• Derma Sciences Inc.
• ConvaTec Inc.
• BMG Pharma S.R.L.
• Acelity
• 3M
• Alliqua BioMedical

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Chemical Vapor Deposition Market is Expected to Enhance $40,731.24 Million Revenue By 2030: Grand View Research Inc.

Chemical Vapor Deposition Market Growth & Trends

The global chemical vapor deposition market is expected to reach USD 40,731.24 million by 2030, registering a CAGR of 8.9% over the forecast period, according to a new report by Grand View Research, Inc. Growth in solar and photovoltaic cells across the world is one of the major drivers of the chemical vapor deposition (CVD) market over the forecast period.

Renewable energy sources, especially, solar cells have been witnessing promising growth and expected to have strong potential over the forecast period. Rising depletion of conventional energy sources and increasing greenhouse gas emission is driving the demand for solar and photovoltaic cells which is expected to boost the CVD market growth.

Additionally, CVD is also used for the manufacturing of the medical devices such as implants which deposits thin film of materials having anticorrosion properties. Rising healthcare spending and advancement in medical device technology is anticipated to drive the growth of the market over the forecast period.

Moreover, rising consumer spending on the electronic devices and products is creating surge in the demand for semiconductors and microelectronics. Semiconductor production is expected to witness strong demand over the forecast period, which is anticipated to drive the growth of the chemical vapor deposition market.

COVID-19 outbreak had negative impact on the chemical vapor deposition market. As a result of lockdown and restriction, industrial manufacturing experienced a setback which affected the demand for chemical vapor deposition market. Over the forecast period, the market is expected to witness promising growth with the resumption of manufacturing.

Companies in the industry are focusing on merger and acquisition, joint venture, product launch, and geographical expansion in order to increase market penetration. For instance, ASM International NV launched new 300 mm vertical batch for LPCVD and ALD in July 2022. The new system will provide advanced facility for memory and logic/foundry applications.

Request a free sample copy or view report summary: Chemical Vapor Deposition Market Report

Chemical Vapor Deposition Market Report Highlights

• The CVD equipment segment led the market with a revenue share of 65.6% in 2022. The higher demand and significant revenue generation from the segment is attributable for higher market share
• The semiconductor and microelectronics application segment dominated the market with a revenue share of 60.3% in 2022. The high market share attributed to the higher demand of CVD in fabrication of chips and semiconductors
• Asia Pacific dominated the market and accounted for revenue share of 51.8% in 2022. High demand from countries such as China and Japan for semiconductor fabrication is attributable for high regional share
• North America is expected to witness a promising CAGR of 8.8% over the forecast period. Growing domestic manufacturing and rising investment in industrial development is anticipated to drive the growth
• In March 2020, ALD NanoSolutions, an ALD expert, merged with Forge Nano, a global player in atomic layer deposition technology. The merger is anticipated to created promising future in atomic level manufacturing.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-chemical-vapor-deposition-cvd-market

Chemical Vapor Deposition Market Segmentation

Grand View Research has segmented the global chemical vapor deposition market on the basis of category, application, and region:

Chemical Vapor Deposition Category Outlook (Revenue, USD Million; 2018 - 2030)

• CVD Equipment
• CVD Materials
• CVD Services

Chemical Vapor Deposition Application Outlook (Revenue, USD Million; 2018 - 2030)

• Semiconductor & microelectronics
• Data Storage
• Solar Products
• Cutting Tools
• Medical Equipment
• Other

Chemical Vapor Deposition Regional Outlook (Revenue, USD Million; 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE

List of Key Players of Chemical Vapor Deposition Market

• CVD Equipment Corporation
• Tokyo Electron Limited
• IHI Corporation
• Veeco Instruments Inc.
• ASM International NV
• Plasma Therm LLC
• Applied Materials Inc.
• Oerlikon Group
• Voestalpine AG
• ULVAC Inc.
• Aixtron SE
• Taiyo Nippon Sanso Corporation
• LPE
• Nuflare Technology Inc.
• RIBER

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Dendritic Cell Cancer Vaccine Market to Reflect Robust Expansion During 2023-2030: Grand View Research Inc.

 Dendritic Cell Cancer Vaccine Market Growth & Trends

The global dendritic cell cancer vaccine market size is expected to reach USD 1.46 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.18% from 2023 to 2030. The rising prevalence of cancer and technological improvement such as drug innovation related to cancer are driving the market growth. According to the WHO, cancer is the leading cause of mortality globally, accounting for around 10 million deaths in 2020.

Immunotherapy is a new approach that strengthens an individual’s immunity to combat different types of carcinoma. Dendritic cell-based immunotherapy vaccination is a well-known and approved approach for enhancing the potential of the immune system to eliminate tumor cells. Many studies are carried out to gauge the efficacy of dendritic cell cancer vaccines. For instance, in June 2020, UbiVac, Inc. signed into a clinical trial collaboration with Bristol Myers Squibb for evaluation of the safety, tolerability, and preliminary efficacy of UbiVac’s investigational product (DPV-001), a dendritic cell-targeted micro-vesicle containing short-lived protein vaccine to explore autophagy, in combination with anti-OX40 (by Bristol Myers Squibb) along with sequenced administration of nivolumab.

Moreover, wide applications of cancer vaccines to boost the immune system are some of the driving factors for market growth. Cancer vaccines are appropriately recognizing and effectively react to antigens associated with carcinoma and kill the carcinogenic cells. They progressively reduce the growth of tumorous cells in the body and induce immunity in an individual to effectively cease the chances of a relapse of cancer condition.

Rising clinical trial activity along with novel product launches create the growth opportunity for market growth. As of November 2022, more than 80 dendritic cell cancer vaccines are under clinical trials. In addition, in June 2021, SPAG9, India's First Indigenous Tumor Antigen, Received a Trademark from DBT-NII. Dendritic cell (DC)-based immunotherapy is being used with ASPAGNIITM for cervical, ovarian, and breast cancers.

Furthermore, key companies in the market undertaking various strategic initiatives to introduce novel are expected to drive the market. For instance, in June 2020, Saint-Gobain Life Sciences signed into a joint collaboration with Kanyr Pharma Inc., the RI-MUHC, and McGill University for research on cancer vaccines based on dendritic cells using single-use culture containers by Saint-Gobain for R&D, clinical-scale and commercial phase production of vaccines.

Request a free sample copy or view the report summary: Dendritic Cell Cancer Vaccine Market Report

Dendritic Cell Cancer Vaccine Market Report Highlights

• By product, the Sipuleucel-T (Provenge) is expected to occupy the largest share of market space due to its advantages in the treatment of castrate-resistant prostate carcinoma.
• By end-use, the adult segment is expected to grow rapidly over the forecast period owing to the rise in the incidence of carcinoma across the globe. The rise in the demand for personalized medicine for the treatment of cancer, also positively impacts the growth of this segment.
• North America dominated the global market in 2022, owing to the rising prevalence of cancers, increasing healthcare expenditure, and rising support for oncology research.
• The Asia Pacific is expected to grow considerably in the future due to the rising prevalence of cancers and high population density. Moreover, key market players are working towards entering the Asia Pacific market with their dendritic cell vaccine expertise. For instance, in May 2021, BGI signed an agreement with the Ethiopian Biotechnology Institute to carry out pilot-scale testing of HPV genotyping to establish a novel technique for HPV screening, diagnosis, and treatment.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-dendritic-cell-cancer-vaccine-market

Dendritic Cell Cancer Vaccine Market Segmentation

Grand View Research has segmented the global dendritic cell cancer vaccine market report based on products, end-use, and region.

Dendritic Cell Cancer Vaccine Product Outlook (Revenue, USD Million, 2018 - 2030)

• CreaVax
• Sipuleucel-T (Provenge)
• Other

Dendritic Cell Cancer Vaccine End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pediatrics
• Adults

Dendritic Cell Cancer Vaccine Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in Dendritic Cell Cancer Vaccine Market

• GlaxoSmithKline plc,
• 3M Company
• Activartis
• Batavia Bioservices,
• Argos Therapeutics
• Sanpower Corporation
• Elios Therapeutics
• DanDrit Biotech
• DCPrime
• ImmunoCellular Therapeutics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

5G Radio Access Network Market To Hold a High Potential for Growth by 2030: Grand View Research Inc.

 5G Radio Access Network Market Growth & Trends

The global 5G radio access network market size is expected to reach USD 66,507.6 million by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 18.4% from 2023 to 2030. Radio access networks (RAN) comprise wireless telecommunications systems, including antennas and base stations, to provide high performing 5G network solutions. It utilizes 5G radio frequency division duplex (FDD) frequencies to connect individual devices through radio connections providing wireless connectivity.

The increasing demand for low latency bandwidth connection and increased focus on research and development activities by key organizations are some of the factors fueling the market growth. This high market size is attributable to the growing deployment of private 5G RAN and core equipment across several use cases. These use cases include smart cities, remote surgeries, enterprises, wireless cameras, industrial robotics, and autonomous vehicles.

RAN encompasses different types, viz. evolved universal terrestrial RAN (E-UTRAN), Universal Radio Access Network (UTRAN), Virtualized Radio Access Network (VRAN), and Open Radio Access Network (ORAN), among others. The robust deployment of a 5G radio access network (RAN) with several small cells and macrocell base stations worldwide is propelling the growth of the market. The RAN base stations within a public mobile network are connected to a public mobile core network through microwave or fiber cables to aggregate signals. The latest RANs offer controllers utilizing software-defined networks (SDN), allowing them to control cellular device capacity and coverage.

The trend of deploying centralized RAN and virtual RAN (VRAN) is rapidly increasing among mobile network operators (MNOs) and network service providers to reduce overall infrastructure costs and network complexities. Rapidly evolving RAN technologies have enabled several key telecom operators and end-use customers to deploy the virtualized network to diminish overall operating expenses. Also, several market players such as Qualcomm Technologies, Inc., Nokia, Verizon, and Cisco Systems, Inc., among others, are significantly focused on providing RAN solutions for private 5G networks, which help clients to transform their existing legacy network infrastructure into the next generation 5G network.

The outbreak of COVID-19 has significantly impacted the global economy and, subsequently, 5G roll-out and 5G RAN deployments. During 2020, there was a notable decline in the imports and exports of 5G hardware equipment from key countries such as the U.S., China, and other key European countries. Therefore, it further hindered the worldwide deployment process of the next-generation network infrastructure. The growth of the 5G RAN market was also impeded due to security concerns in maintaining network data, operational continuity, and new traffic patterns.

A few companies working in 5G RAN are Telefonaktiebolaget LM Ericsson, Qualcomm Technologies, Inc., Nokia, Intel Corporation, Samsung, Verizon, Cisco Systems, Inc., Huawei Technologies Co., Ltd., VMware, Inc., Rakuten Symphony Singapore Pte. Ltd, among others. In October 2022, Qualcomm Technologies, Inc. announced a collaboration with Vodafone Group to develop and integrate next-generation 5G radio units and distributed units with massive multiple-input multiple-output capabilities. The companies are also developing 5G ORAN infrastructure solutions powered by Qualcomm QRU100 5G radio access network platform and Qualcomm X100 5G RAN accelerator card. 

Request a free sample copy or view report summary: 5G Radio Access Network Market Report

5G Radio Access Network Market Report Highlights

• Radio access networks comprise wireless telecommunications systems, including antennas and base stations, to provide high performing 5G network solutions.
• The robust deployment of a 5G radio access network (RAN) with several small cells and macrocell base stations worldwide is propelling the growth of the market
• The trend of deploying centralized RAN and virtual RAN (VRAN) is rapidly increasing among mobile network operators (MNOs) and network service providers to reduce overall infrastructure costs and network complexities
• In terms of components, the hardware segment is expected to dominate the market and expand at a CAGR of 16.2% from 2023 to 2030
• The 5G ORAN market is projected to grow at the highest CAGR of 28.5% within the architecture type, during the forecast period
• In terms of deployment, the outdoor deployment of 5G RAN is expected to dominate in 2022, gaining a market share of more than 60%
• The enterprise segment is projected to grow at the highest CAGR of 26.1% within the end-user of the 5G RAN market during the forecast period
• The primary source markets for 5G RAN are the U.S., Japan, China, India, the U.K., Canada, Germany, France, and Brazil. The U.S. will be the primary source market for 5G RAN companies

Access Press Release@ https://www.grandviewresearch.com/press-release/global-5g-radio-access-network-market

5G Radio Access Network Market Segmentation

Grand View Research has segmented the global 5G radio access network (RAN) market based on component, architecture type, deployment, end-user, and region:

5G Radio Access Network Component Outlook (Revenue, USD Million, 2019 - 2030)

• Hardware
  • Antennas
    • MIMO
    • Beamforming
    • Others (Monopole, Dipole, Microstrip, Patch Antennas)
  • Radio Unit
  • Baseband Units
• Software
• Services
  • Managed Services
  • Consulting Services
  • Professional Services
    • Planning & Design Services
    • Integration & Validation Services
    • Deployment Services
    • Optimization and Performance Improvement Services

5G Radio Access Network Architecture Type Outlook (Revenue, USD Million, 2019 - 2030)

• CRAN
• ORAN
• VRAN

5G Radio Access Network Deployment Outlook (Revenue, USD Million, 2019 - 2030)

• Indoor
• Outdoor

5G Radio Access Network End-user Outlook (Revenue, USD Million, 2019 - 2030)

• Telecom Operators
• Enterprises

5G Radio Access Network Regional Outlook (Revenue, USD Million, 2019 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
• Asia-Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
• Middle East & Africa

List of Key Players in the 5G Radio Access Network Market

• Telefonaktiebolaget LM Ericsson
• Qualcomm Technologies, Inc.
• Nokia
• Intel Corporation
• Samsung
• Verizon
• Cisco Systems, Inc.
• Huawei Technologies Co., Ltd.
• VMware, Inc.
• Rakuten Symphony Singapore Pte. Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Chronic Wound Care Market Latest Innovations, Drivers and Industry Key Events 2023 – 2030: Grand View Research Inc.

 Chronic Wound Care Market Growth & Trends

The global chronic wound care market size is expected to reach a value of USD 17.6 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 4.07% from 2023 to 2030. Diabetes may increase the overall frequency and complexity of wounds such as infections, ulcerations (leg or foot ulcers), and chronic wounds, including surgical & traumatic wounds. For instance, according to a research article published in March 2021 by ScienceDirect, the prevalence of diabetes is expected to increase to 120 million people in 2030, thereby propelling market growth.

The outbreak of COVID-19 has created large-scale opportunities for local manufacturers. Due to the restrictions on movement at international borders, the supply chain of major players has been disrupted. This has created an opportunity for local players to enter the market and meet the unmet demands of the end-users. The rising number of cases has led to a shortage of medical supplies; thus, local players are manufacturing products on a larger scale to meet the growing need. Moreover, to enhance their foothold in the market, key companies are adopting various plans and policies to gain a higher market share.

Technological advancements are projected to have a significant impact on the advanced wound care industry in the coming years. The quality of life of patients suffering from chronic wounds improves as technology advances and becomes more affordable. Traditional wound care and closure products are gradually being replaced by advanced wound care & closure products due to their efficacy and effectiveness in wound management by allowing quicker healing.

Request a free sample copy or view the report summary: Chronic Wound Care Market Report

Chronic Wound Care Market Report Highlights

• Advanced wound dressing was identified as the highest revenue-generating segment in 2022 due to its major usage in the treatment of chronic and non-healing wounds
• In 2022, foam dressing was the highest revenue-generating advanced wound dressings sub-segment as this dressing absorbs moisture that aids in maintaining the integrity of the tissue
• The hospitals segment held the largest revenue share amongst various end-use channels in 2022, owing to increasing footfall. Also, surgical wound care dressings and NPWT are predominantly suitable for treatment in hospital
• North America held the largest revenue share in the market in 2022 due to the availability of skilled professionals and improvement in healthcare infrastructure

Access Press Release@ https://www.grandviewresearch.com/press-release/global-chronic-wound-care-market

Chronic Wound Care Market Segmentation                  

Grand View Research has segmented the global chronic wound care market based on product, application, end-use, and region:

Chronic Wound Care Product Outlook (Revenue, USD Million, 2018 - 2030)

• Advanced Wound Dressing
  • Foam Dressing
  • Hydrocolloid Dressing
  • Film Dressing
  • Alginate Dressing
  • Hydrogel Dressing
  • Collagen Dressing
  • Other Dressing
• Surgical Wound Care
  • Suture & Staples
  • Tissue Adhesive & Sealants
  • Anti-infective Dressing
• Traditional Wound Care
  • Medical Tapes
  • Cleansing Agents
  • Others
• Wound Therapy Devices
  • Negative Pressure Wound Therapy
  • Oxygen and Hyperbaric Oxygen Equipment
  • Electric Stimulation Devices
  • Pressure Relief Devices
  • Others

Chronic Wound Care Application Outlook (Revenue, USD Million, 2018 - 2030)

• Diabetic Foot Ulcers
• Pressure Ulcers
• Venous Leg Ulcers
• Others

Chronic Wound Care End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Specialty Clinics
• Home Healthcare
• Others

Chronic Wound Care Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in Chronic Wound Care Market                                                                    

• JOHNSON & JOHNSON
• BAXTER INTERNATIONAL
• Coloplast Corp.
• 3M
• Medline Industries, Inc.
• ConvaTec Group PLC
• Derma Sciences (Integra LifeSciences)
• Mölnlycke Health Care AB
• Paul Hartmann AG
• Smith & Nephew PLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Surgical Masks Market Witness Excellent Revenue Growth During 2023-2030: Grand View Research Inc

 

Surgical Masks Market Growth & Trends

The global surgical masks market size is expected to reach USD 1871.6 million by 2030, registering a CAGR of 7.1% during the forecast period, according to a new report by Grand View Research, Inc. Increasing healthcare expenditure coupled with rising awareness regarding HAIs is expected to drive the demand for surgical masks during the forecast period.

The demand for healthcare services and products has led to increased use of personal protective equipment such as coveralls, gowns, bouffant caps, shoe covers, masks, gloves, and essentially surgical masks. In addition, the increasing geriatric population is anticipated to boost the demand for medical essentials such as surgical masks.

Government authorities such as the Centers for Disease Control and Prevention have issued guidelines pertaining to the use of sterile barrier precautions such as the use of gloves, surgical masks, gowns, and drapes. The aforementioned factors are, in turn, anticipated to have a positive impact on the growth of the market during the forecast period.

Surgical masks, N95 respirators, or medical respirators are recommended to be used by healthcare professionals directly exposed to SARS-CoV-2. Owing to the need for airway instrumentation and close contact with patients, perioperative professionals are at a higher risk of infections in all therapeutic, diagnostic, and surgical procedures during the pandemic.

According to the World Health Organization (WHO), millions of patients are affected by HAIs globally every year causing mortality and financial losses for the healthcare systems. Furthermore, 10 out of 100 hospitalized patients are infected with HAIs in developing economies and 7 in developed economies. These factors in turn are estimated to drive the demand for surgical masks.

The global market is highly competitive with major companies striving for market leadership. Strategies employed by companies include the expansion of production capacities and distribution networks. In addition, to meet the surging demand for face masks amidst the pandemic, several manufacturers are increasing their production capacities.

Request a free sample copy or view report summary: Surgical Masks Market Report

Surgical Masks Market Report Highlights

• Basic surgical masks dominated the market and accounted for over 43.0% share in 2022 owing to their widespread demand from the healthcare sector and easy availability across hospitals and online distribution platforms
• The offline distribution channel segment dominated the market and accounted for over 55.2% share in 2022. This segment is expected to play an important role in market growth on account of its convenience and goodwill among consumers
• The anti-fog foam surgical mask segment is expected to expand at a CAGR of 7.3% during the forecast period. It creates a seal between the user’s face and the mask, which further prevents the eyeglasses from fogging and ensures optical clarity
• Europe dominated the market and accounted for over 34.4% share in 2022. The rising number of qualified nurses and midwives, associate nurses, and other care professionals is responsible for the increased demand for surgical masks
• In January 2021, 3M augmented its annual production rate of N95 respirators to about 2.5 billion units. In addition, since the outbreak of the COVID-19 pandemic, the company has responded with cash and product donations.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-surgical-masks-market

Surgical Masks Market Segmentation

Grand View Research has segmented the global surgical masks market based on product, distribution channel, and region:

Surgical Masks Product Outlook (Revenue, USD Million, 2018 - 2030)

• Basic Surgical Masks
• Anti-fog Foam Surgical Masks
• Fluid/Splash Resistant Surgical Masks
• Others

Surgical Masks Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Online
• Offline

Surgical Masks Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Thailand
  • Indonesia
  • Malaysia
• Central & South America
  • Brazil
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa

List of Key Players in the Surgical Masks Market 

• 3M
• DuPont
• Ansell Ltd.
• Owens & Minor
• Medline Industries, LP.
• Cardinal Health
• Crosstex International, Inc.
• KCWW
• ALPHAPROTECH
• Dynarex Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Personal Care Contract Manufacturing Market Set to Record Exponential Growth by 2030: Grand View Research Inc.

 U.S. Personal Care Contract Manufacturing Market Growth & Trends

The U.S. personal care contract manufacturing market size is anticipated to reach USD 5.22 billion by 2030, registering a CAGR of 7.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing personal care products industry is an important factor contributing to the growth of the personal care contract manufacturing market in the U.S.

The personal care products are available with a deep product assortment and made with different formulations. The U.S. personal care product market has a presence of multiple brands offering different benefits to customers. To manufacture such a wide range of products demand for mass customization is high. In this scenario, an external contract manufacturer can easily manufacture products with different formulations. Hence to cater to the requirement of mass customization the demand for personal care contract manufacturers is expected to remain high over the forecast period.

In the U.S., personal care product companies are concentrating more on research & development and new product launches than on actual product manufacturing. This approach has been adopted by various brands to remain relevant in the highly competitive market. These operational choices enable these businesses to maximize their resource usage. Hence personal care product brands are undertaking outsourcing initiatives to focus more on innovation, marketing, and distribution. Because of this element, the personal care contract manufacturing market's overall growth in the U.S. is expected to rise throughout the forecast period.

Technological advancements have significantly transformed the landscape of the personal care contract manufacturing market, offering numerous benefits in terms of efficiency, quality, and innovation. Furthermore, technological advancements, particularly in automation, have revolutionized production processes in personal care contract manufacturing. Automated systems streamline tasks such as mixing, filling, and packaging, leading to increased efficiency, precision, and reduced labor costs. Hence with the rising technological advancements, the demand for personal care contract manufacturing is anticipated to remain high.

The demand for organic personal care products has been growing significantly. Hence the buyers are seeking contract manufacturers capable of manufacturing formulations with eco-friendly and ethically sourced ingredients. Companies focusing on sustainability in their manufacturing processes are more likely to develop the market. Hence buyers are interested in contract manufacturers capable of producing products with health benefits.

Request a free sample copy or view report summary: U.S. Personal Care Contract Manufacturing Market Report

U.S. Personal Care Contract Manufacturing Market Report Highlights

• Based on service, the manufacturing segment dominated the market and accounted for a revenue share of 88.3% in 2023, as OEMs are focusing on outsourcing the production of personal care products by adopting a private label strategy
• Personal care contract manufacturers are using an Enterprise Resource Planning (ERP) system. This system has been effectively optimizing the manufacturing operations by managing the entire production lifecycle, from ingredient sourcing to product distribution, ensuring real-time visibility and data accuracy
• The contract manufacturers have developed technological compatibility to attain high-quality manufacturing, hence it’s very difficult for brands to switch to other contractors for the manufacturing of products. Due to this threat of substitutes has remained low for the market
• The rise of e-commerce has been a significant trend. With consumers purchasing the personal care products online, the sales of personal care products have been rising significantly. This factor is further propelling the personal care contract manufacturing market in the U.S

Access Press Release@ https://www.grandviewresearch.com/press-release/us-personal-care-contract-manufacturing-market-analysis

U.S. Personal Care Contract Manufacturing Market Segmentation

Grand View Research has segmented the U.S. personal care contract manufacturing market based on service:

U.S. Personal Care Contract Manufacturing Service Outlook (Revenue, USD Million, 2018 - 2030)

• Manufacturing
  • Skin Care
  • Hair Care
  • Make-up & Color Cosmetics
  • Fragrances & deodorants
  • Others
• Custom Formulation and R&D
  • Skin Care
  • Hair Care
  • Make-up & Color Cosmetics
  • Fragrances & deodorants
  • Others
• Packaging
  • Skin Care
  • Hair Care
  • Make-up & Color Cosmetics
  • Fragrances & deodorants
  • Others

List of Key Players in the U.S. Personal Care Contract Manufacturing Market

• NuWorld
• Biogenesis
• Bright International
• Fareva
• Intercos S.p.A.
• 220 Laboratories
• C-Care
• Accupack Midwest, Inc.
• Eco Lips, Inc.
• Verla International, Ltd

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Bathroom Cabinets Market Expected to Succeed in CAGR of 6.1% by 2030

 Bathroom Cabinets Market Growth and Trends

The global bathroom cabinets market size is expected to reach USD 112.99 billion by 2030, expanding at a CAGR of 6.1% from 2022 to 2030, according to a new report by Grand View Research, Inc. The demand is attributed to the increasing number of residential construction and commercial construction such as hotels and gyms. In addition, the growing penetration of bathroom vanities, allowing different space configurations and improving the aesthetic appeal of the bathroom, is expected to drive the market demand. Furthermore, the home renovation and remodeling trend are expected to emerge as a key driving factor for the growth of the market.

The bathroom cabinet market is expected to experience strong growth in the coming years. According to the statistics published by National Kitchen & Bath Association in January 2022, kitchen and bathroom product spending is expected to reach USD 199 billion and witness 19% growth for the second year in a row. With the rise in disposable income, consumers across the globe are willing to spend more on advanced bathroom and kitchen products such as LED-enabled mirrors and cabinets. Such products offer aesthetic appeal to the bathroom thus contributing to the market growth.

The leading manufacturers such as Duravit, Laufen Bathrooms AG, Geberit AG, Roca, Nilkamal, W. Schneider+Co AG are investing in R&D activities to enhance the design and economic aspects of such mirror cabinets. Vendors are adopting various organic and inorganic strategies such as joint ventures, mergers & acquisitions, and collaborations, and new product offerings, to enhance their foothold in the industry. For instance, in June 2021, Roca Sanitario, S.A launched ROMEA, a new range of bathroom furniture with a vintage style. The newly launched product is a Romea classic bathroom cabinet that can be complemented with a matching mirror and other furniture products. Such initiatives are expected to drive growth in the coming years.

Request a free sample copy or view report summary: Bathroom Cabinets Market Report

Bathroom Cabinets Market Report Highlights

• Asia Pacific contributed the largest market share of the global revenue in 2021. China accounted for the largest market share in 2021 followed by Japan, and India. Growing demand for mirrored bathroom cabinets from countries such as China, and India owing to the growing disposable income and increasing spending on home décor is expected to drive the growth of the market
• The wood segment contributed to the highest share of the global market revenue in 2021 and is expected to escalate at the highest CAGR during the forecast period. Steel cabinet is projected to grow at a significant CAGR during the forecast period, as steel cabinet adds to the aesthetic appeal of the bathroom
• The residential application segment occupied the largest share in 2021 and is projected to register a significant growth rate during the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/global-bathroom-cabinets-market

Bathroom Cabinets Market Segmentation

Grand View Research has segmented the global bathroom cabinets market based on type, material, product, application, and region.

Bathroom Cabinets Type Outlook (Revenue, USD Million, 2017 - 2030)

• With Mirror
• Without Mirror

Bathroom Cabinets Material Outlook (Revenue, USD Million, 2017 - 2030)

• Wood
• Metal
• Others

Bathroom Cabinets Product Outlook (Revenue, USD Million, 2017 - 2030)

• Single Door
• Multi Door

Bathroom Cabinets Application Outlook (Revenue, USD Million, 2017 - 2030)

• Residential
• Commercial

Bathroom Cabinets Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
• Central & South America
  • Brazil
• Middle East & Africa
  • South Africa

List of Key Players in the Bathroom Cabinets Market

• Geberit AG
• Roca
• Nilkamal
• Duravit
• Laufen Bathrooms AG
• Schneider+Co AG
• HiB
• Emco group
• Roper Rhodes Ltd
• FAB Glass

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Plasmid DNA Contract Manufacturing Market Is Booming Worldwide 2023-2030

 Plasmid DNA Contract Manufacturing Market Growth & Trends

The global plasmid DNA contract manufacturing market size is expected to reach USD 1,117.5 million by 2030, registering a CAGR of 19.3%, according to a new report by Grand View Research, Inc. The growing popularity of cell & gene therapy, prevalence of chronic diseases is increasing and plasmid DNA has a wide range of uses in the healthcare sector are the key factors driving the growth of the market.

The field of gene therapy significantly broaden the treatment of viral infections, malignancies, hereditary illnesses, and immunotherapy. The therapy is, however, not yet widely used in clinical settings, and licenses have often only been given in particular countries. Examples of gene treatments include Spinraza, which is used to treat spinal muscular atrophy. However, government assistance, assuring sustainability, community involvement, enacting suitable regulatory legislation, and promoting entrepreneurship are vital to the success of any gene therapy programs in Africa. Hence, the growing adoption of gene therapy in the treatment of cancer is propelling the growth of the plasmid DNA contract manufacturing market.

However, the COVID-19 resulted into positive impact on the plasmid DNA contract manufacturing market. There was an increase in demand for vaccines during the COVID-19 pandemic. The market would certainly benefit from the efforts of biotechnology companies that produce COVID-19 vaccines made from plasmid DNA. In 2022, it is anticipated that the incidence of COVID-19 would increase, thus advancing the need for COVID-19 vaccinations. For instance, India recently became the first country in the world to approve a COVID-19 DNA plasmid vaccine. The ZyCoV-D vaccine has received the Drugs Controller General of India's emergency clearance, making it the sixth vaccine to receive approval in India. Furthermore, it is the only vaccine that has been approved for adolescents between the ages of 12 and 18. The fact that a DNA vaccination has been authorized for use in people for the first time, according to researchers from all around the world, makes the approval significant.

Request a free sample copy or view report summary: Plasmid DNA Contract Manufacturing Market Report

Plasmid DNA Contract Manufacturing Market Report Highlights

• Cell & gene therapy dominated the market with a revenue share of 60.3% in 2022. The growing confidence of people in the dependability, efficiency, and safety of gene treatments in the treatment of a wide range of chronic and genetic disorders drives the growth of the segment.
• Based on therapeutic areas, cancer dominated the segment with a revenue share of 39.0% in 2022. The growing number of cancer cases increases the demand for cancer treatment therapies.
• Pharmaceutical and Biotechnology Companies dominated the market with a revenue share of 59.2% in 2022. There is a growing demand for innovative therapies requiring plasmid DNA. The companies investing in research also help to propel the segment market.
• Asia Pacific is anticipated to register the fastest CAGR growth of 19.9% during the forecast period. The high burden of diseases, growing cancer cases, and growing adoption of plasmid DNA for developing vaccines and drugs for various diseases are the key factors driving the growth of the market in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-plasmid-dna-contract-manufacturing-market

Plasmid DNA Contract Manufacturing Market Segmentation

Grand View Research has segmented the global plasmid DNA contract manufacturing market based on application, therapeutic, end-user, and region:

Plasmid DNA Contract Manufacturing Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cell & Gene Therapy
• Immunotherapy
• Others

Plasmid DNA Contract Manufacturing Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)

• Cancer
• Infectious Diseases
• Autoimmune Diseases
• Cardiovascular Diseases
• Others

Plasmid DNA Contract Manufacturing End-user Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical and Biotechnology Companies
• Research Institutes

Plasmid DNA Contract Manufacturing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Rest of EU
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Rest of MEA

List of Key Players of Plasmid DNA Contract Manufacturing Market

• Charles River Laboratories
• VGXI, Inc.
• Plasmid Factory GmbH & Co. KG
• Boehringer Ingelheim BioXcellence
• BioCina
• TriLink Biotechnologies
• Esco Aster PTE. LTD
• Thermo Fisher Scientific, Inc.
• VIVE biotech
• Lonza

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.